U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556861) titled 'A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients' on April 22.
Brief Summary: The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Study Start Date: May 16
Study Type: INTERVENTIONAL
Condition:
Bipolar Disorder
Substance Use (Drugs, Alcohol)
Intervention:
OTHER: Senyo Health App
The Senyo Health app includes asynchronous cognitive behavioral therapy (CBT) modules, contingency manageme...